Literature DB >> 24011376

Characterization and suitability of therapeutic antibody dense phases for subcutaneous delivery.

Harvey R Johnson1, Abraham M Lenhoff.   

Abstract

Subcutaneous antibody dosing formulations comprising solid suspensions have the potential to reduce dosage viscosity and injection volume. Gel beads of three therapeutic antibodies were prepared to determine the feasibility of such formulations. The beads were formed directly from aqueous solution within 0.1-4 days upon addition of biocompatible precipitating agents under conditions compatible with the use of stabilizing excipients. The phase behavior of antibody gel beads and their mechanical characteristics were measured. Gel beads were characterized by reduced elastic moduli of 0.4-1.0 MPa, as measured by atomic force microscopy, and completely redissolved within 10-20 min under physiologic conditions, in vitro. Crystalline particles could also be prepared in some cases and were found to have reduced elastic moduli 3 orders of magnitude greater than those for the gel beads. Both crystalline and gel particles had protein concentrations of 100-180 mg/mL within the dense phase. Protein stored within the dense phase was recoverable after 40 days of incubation at room temperature or 4 °C.

Mesh:

Substances:

Year:  2013        PMID: 24011376     DOI: 10.1021/mp400006g

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

1.  Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.

Authors:  Pilarin Nichols; Li Li; Sandeep Kumar; Patrick M Buck; Satish K Singh; Sumit Goswami; Bryan Balthazor; Tami R Conley; David Sek; Martin J Allen
Journal:  MAbs       Date:  2015       Impact factor: 5.857

2.  Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties.

Authors:  Li Li; Sandeep Kumar; Patrick M Buck; Christopher Burns; Janelle Lavoie; Satish K Singh; Nicholas W Warne; Pilarin Nichols; Nicholas Luksha; Davin Boardman
Journal:  Pharm Res       Date:  2014-06-07       Impact factor: 4.200

3.  A comparative study of monoclonal antibodies. 1. Phase behavior and protein-protein interactions.

Authors:  Rachael A Lewus; Nicholas E Levy; Abraham M Lenhoff; Stanley I Sandler
Journal:  Biotechnol Prog       Date:  2014-11-19

4.  Droplet-Based Microfluidic Tool to Quantify Viscosity of Concentrating Protein Solutions.

Authors:  Deyu Yang; Maryam Daviran; Kelly M Schultz; Lynn M Walker
Journal:  Pharm Res       Date:  2021-10-18       Impact factor: 4.200

Review 5.  Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers.

Authors:  D S Collins; L C Kourtis; N R Thyagarajapuram; R Sirkar; S Kapur; M W Harrison; D J Bryan; G B Jones; J M Wright
Journal:  Pharm Res       Date:  2017-07-13       Impact factor: 4.200

6.  Stability of a high-concentration monoclonal antibody solution produced by liquid-liquid phase separation.

Authors:  Jack E Bramham; Stephanie A Davies; Adrian Podmore; Alexander P Golovanov
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.